These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23378484)

  • 21. Designing and evaluating dose-escalation studies made easy: The MoDEsT web app.
    Pallmann P; Wan F; Mander AP; Wheeler GM; Yap C; Clive S; Hampson LV; Jaki T
    Clin Trials; 2020 Apr; 17(2):147-156. PubMed ID: 31856600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Care Research Team Assessment (PCRTA): development and evaluation.
    Carter YH; Shaw S; Macfarlane F
    Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study.
    Connor JT; Luce BR; Broglio KR; Ishak KJ; Mullins CD; Vanness DJ; Fleurence R; Saunders E; Davis BR
    Clin Trials; 2013 Oct; 10(5):807-27. PubMed ID: 23983160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative costs and activity from a sample of UK clinical trials units.
    Hind D; Reeves BC; Bathers S; Bray C; Corkhill A; Hayward C; Harper L; Napp V; Norrie J; Speed C; Tremain L; Keat N; Bradburn M
    Trials; 2017 May; 18(1):203. PubMed ID: 28464930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of risk-based monitoring in pragmatic trials in UK Clinical Trials Units.
    Beever D; Swaby L
    Trials; 2019 Sep; 20(1):556. PubMed ID: 31500656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decision-theoretic designs for phase II clinical trials allowing for competing studies.
    Stallard N
    Biometrics; 2003 Jun; 59(2):402-9. PubMed ID: 12926725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study.
    Tume LN; Woolfall K; Arch B; Roper L; Deja E; Jones AP; Latten L; Pathan N; Eccleson H; Hickey H; Parslow R; Preston J; Beissel A; Andrzejewska I; Gale C; Valla FV; Dorling J
    Health Technol Assess; 2020 May; 24(23):1-120. PubMed ID: 32458797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
    Adrion C; Mansmann U
    BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
    Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ
    Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian statistical methods in public health and medicine.
    Etzioni RD; Kadane JB
    Annu Rev Public Health; 1995; 16():23-41. PubMed ID: 7639872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. District decision-making for health in low-income settings: a case study of the potential of public and private sector data in India and Ethiopia.
    Bhattacharyya S; Berhanu D; Taddesse N; Srivastava A; Wickremasinghe D; Schellenberg J; Iqbal Avan B
    Health Policy Plan; 2016 Sep; 31 Suppl 2(Suppl 2):ii25-ii34. PubMed ID: 27591203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding current practice, identifying barriers and exploring priorities for adverse event analysis in randomised controlled trials: an online, cross-sectional survey of statisticians from academia and industry.
    Phillips R; Cornelius V
    BMJ Open; 2020 Jun; 10(6):e036875. PubMed ID: 32532777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
    Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
    Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive trial designs.
    Lai TL; Lavori PW; Shih MC
    Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.
    Bauer P; Bretz F; Dragalin V; König F; Wassmer G
    Stat Med; 2016 Feb; 35(3):325-47. PubMed ID: 25778935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian statistics in medical devices: innovation sparked by the FDA.
    Campbell G
    J Biopharm Stat; 2011 Sep; 21(5):871-87. PubMed ID: 21830920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Bayesian methods make data and analyses more relevant to decision makers? A perspective from Medicare.
    Sheingold SH
    Int J Technol Assess Health Care; 2001; 17(1):114-22. PubMed ID: 11329838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center.
    Biswas S; Liu DD; Lee JJ; Berry DA
    Clin Trials; 2009 Jun; 6(3):205-16. PubMed ID: 19528130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive designs in clinical trials: why use them, and how to run and report them.
    Pallmann P; Bedding AW; Choodari-Oskooei B; Dimairo M; Flight L; Hampson LV; Holmes J; Mander AP; Odondi L; Sydes MR; Villar SS; Wason JMS; Weir CJ; Wheeler GM; Yap C; Jaki T
    BMC Med; 2018 Feb; 16(1):29. PubMed ID: 29490655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.